Theravance Biopharma, Inc. (TBPH)

NASDAQ

$17.04

$+0.01

(+0.06%)

After-Hours

Theravance Biopharma, Inc. (TBPH) Live Price Chart

Last updated: ⁦2026-10-20 20:39:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Theravance Biopharma, Inc. (TBPH) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $17.04, with a market capitalization of $884.18M and a P/E ratio of 16.43. Over the past 52 weeks, its price has ranged from $13.08 to $21.03. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$884.18M
Open	$17.06
Day's High	$43.44
Day's Low	$6.10
Previous Close	$17.03
Volume	2.35M
Average Volume	868.92K
P/E Ratio	16.43
52-Week High	$21.03
52-Week Low	$13.08
Dividend Yield	--
Earnings Date	--

Theravance Biopharma, Inc. (TBPH) After-Hours Stock Price

Theravance Biopharma, Inc. (TBPH) is trading at $17.05 in after-hours trading as of 2026-09-23 23:31:00, up 0.09% ($0.02) from the regular-session close of $17.03.

After-hours trading shows how investors are pricing TBPH after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.

Theravance Biopharma, Inc. (TBPH) 7-Day Stock Price Change

Over the past seven days, Theravance Biopharma, Inc. (TBPH) moved from $17.04 to $17.04, representing a decline of 0.03% ($0.00).

The stock traded between $17.02 and $17.08 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.

The average daily volume was 2.68 million shares, up versus the previous seven-day period, indicating higher trading activity.

TBPH 52-Week Price Position

Position in Range: 49.7%

52W Low$13.08

52W High$21.03

TBPH is currently trading at $17.04, placing it 49.7% of the way from its 52-week low of $13.08 to its 52-week high of $21.03. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Theravance Biopharma, Inc. (TBPH)?

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Theravance Biopharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	90
Exchange	NASDAQ
Company Website	https://www.theravance.com

How to Buy Theravance Biopharma, Inc. (TBPH) Stock on MEXC

Eligible investors can buy real shares of Theravance Biopharma, Inc. (TBPH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TBPH and Place Your Order

Open the RealStocks trading page and search for TBPH. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Theravance Biopharma, Inc. (TBPH) stock price today?

Theravance Biopharma, Inc. (TBPH) is currently trading at $ 17.04, up 0.03% ($0.00) from the previous close of $ 17.03. Intraday prices update in real time during regular trading hours.

2.Is TBPH stock going up or down today?

As of 2026-09-23 23:31:00, TBPH is trading at $ 17.04, up 0.03% ($0.00) from its previous close of $ 17.03. The stock has traded between $ 6.10 and $ 43.44 during today’s regular session. Past price movements do not guarantee future results.

3.What is TBPH pre-market price?

As of 2026-09-23 23:31:00, TBPH is trading at $ 17.05 in pre-market trading, up 0.09% ($0.02) from the previous close of $ 17.03. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TBPH after-hours price?

As of 2026-09-23 23:31:00, TBPH is trading at $ 17.05 in after-hours trading, up 0.09% ($0.02) from the regular-session close of $ 17.03. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TBPH stock trading now?

TBPH trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TBPH sit relative to its 52-week high and low?

Over the past 52 weeks, TBPH has traded between a low of $ 13.08 and a high of $ 21.03. At $ 17.04, the stock is positioned 49.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Theravance Biopharma, Inc. in?

Theravance Biopharma, Inc. (TBPH) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Theravance Biopharma, Inc.'s market capitalization and where is it listed?

Theravance Biopharma, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 884.18M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TBPH valued in terms of P/E ratio and EPS?

TBPH trades at a P/E ratio of 16.43, based on trailing-twelve-month EPS of $ 1.04. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Theravance Biopharma, Inc. pay a dividend?

Theravance Biopharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.